InvestorsHub Logo
Followers 155
Posts 2640
Boards Moderated 0
Alias Born 01/29/2004

Re: Investor2014 post# 301186

Monday, 03/01/2021 12:56:14 PM

Monday, March 01, 2021 12:56:14 PM

Post# of 461941
Autism applications would be awesome.

The most likely is an Autism Spectrum Disorder...

If an Anavex molecule proves to be either prophylactic or therapeutic for autism, consider the numbers.

About 1 in 54 children has been identified with autism spectrum disorder (ASD) according to estimates from CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network.
https://www.cdc.gov/ncbddd/autism/data.html

Almost 2% of kids born today are intellectually and behaviorally hindered by autism. If an Anavex molecule could reduce that by any fraction it would be a major revenue source for the company — and save billions of dollars for both parents and societies. It would be one of the major drug advances since antibiotics and psychotherapeutics.

May it be so.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News